Pembrolizumab
Merck
['mbc']
#esmo22 marra et al in mbc more apobec in ilc and higher tmb hrd worse outcomes on first line et pi3k mutations enriched in apobec tumours 
Medical oncologist from Perth - Australia. Interested in thoracic oncology, breast cancer, GUs, clinical trials, fast cars (Formula 1) and @werderbremen_en